Quarterly ResultApr 23, 2026, 04:17 PM
CHEMED Q1 Revenue Up 1.6%, Raises Full-Year Guidance
AI Summary
Chemed Corporation reported Q1 2026 financial results, with consolidated revenue increasing 1.6% to $657.5 million and adjusted diluted EPS rising 0.4% to $5.65. The company increased its full-year guidance, citing strong VITAS performance. During the quarter, Chemed repurchased 500,000 shares and acquired two Roto-Rooter franchises for $20.6 million.
Key Highlights
- Consolidated revenue increased 1.6% to $657.5 million.
- Adjusted Diluted EPS rose 0.4% to $5.65.
- VITAS segment net patient revenue increased 3.1% to $420.0 million.
- Repurchased 500,000 shares in the quarter.
- Acquired two Roto-Rooter franchises for $20.6 million.